Top Cited Articles

To celebrate another year of high quality, cutting edge content published in Thorax, we have shortlisted the top cited research of the past 3 years. These articles have all be made free to access as a thank you to our authors and readers.

2018

Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosis
Lucile Sese, Hilario Nunes, Vincent Cottin, et al.
10.1136/thoraxjnl-2017-209967

Using hyperpolarized Xe-129 MRI to quantify regional gas transfer in idiopathic pulmonary fibrosis
Jennifer M. Wang, Scott H. Robertson, Ziyi Wang, et al.
10.1136/thoraxjnl-2017-210070

Does training respiratory physicians in clinical respiratory physiology and interpretation of pulmonary function tests improve core knowledge?
M Patout, L Sese, T Gille, et al.
10.1136/thoraxjnl-2016-209136

Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis
Robert D. Gray, Gareth Hardisty, Kate H. Regan, et al.
10.1136/thoraxjnl-2017-210134

Intensive versus standard physical rehabilitation therapy in the critically ill (EPICC): a multicentre, parallel-group, randomised controlled trial
Stephen E. Wright, Kirsty Thomas, Gillian Watson, et al.
10.1136/thoraxjnl-2016-209858

British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma
Ian Woolhouse, Lesley Bishop, Liz Darlison, et al.
10.1136/thoraxjnl-2017-211321

The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers
Nicola J. Rowbotham, Sherie Smith, Paul A. Leighton, et al.
10.1136/thoraxjnl-2017-210473

Polysomnographic phenotypes and their cardiovascular implications in obstructive sleep apnoea
Andrey V. Zinchuk, Sangchoon Jeon, Brian B. Koo, et al.
10.1136/thoraxjnl-2017-210431

Lung function response and side effects to rapamycin for lymphangioleiomyomatosis: a prospective national cohort study
Janet Bee, Sharon Fuller, Suzanne Miller, et al.
10.1136/thoraxjnl-2017-210872

One evidence base; three stories: do opioids relieve chronic breathlessness?
Magnus Ekstrom, Sabrina Bajwah, J. Martin Bland, et al.
10.1136/thoraxjnl-2016-209868

2017

Chest electrical impedance tomography examination, data analysis, terminology, clinical use and recommendations: consensus statement of the TRanslational EIT developmeNt stuDy group
Inéz Frerichs, Marcelo B. P. Amato, Anton H. van Kaam, et al.
10.1136/thoraxjnl-2016-208357

British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
Charles S. Haworth, John Banks, Toby Capstick, et al.
10.1136/thoraxjnl-2017-210927

Physical activity is increased by a 12-week semiautomated telecoaching programme in patients with COPD: a multicentre randomised controlled trial
H. Demeyer, Z. Louvaris, A. Frei, et al.
10.1136/thoraxjnl-2016-209026

Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval
Uraujh Yousaf-Khan, Carlijn van der Aalst, Pim A. de Jong, et al.
10.1136/thoraxjnl-2016-208655

Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
Martin Kolb, Luca Richeldi, Juergen Behr, et al.
10.1136/thoraxjnl-2016-208710

Home-based rehabilitation for COPD using minimal resources: a randomised, controlled equivalence trial
Anne E. Holland, Ajay Mahal, Catherine J. Hill, et al.
10.1136/thoraxjnl-2016-208514

BTS guideline for oxygen use in adults in healthcare and emergency settings
R. O’Driscoll, L. S. Howard, J. Earis, et al.
10.1136/thoraxjnl-2016-209729

The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia
Robert Brownell, Teng Moua, Travis S. Henry, et al.
10.1136/thoraxjnl-2016-209671

A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD
Tom M. A. Wilkinson, Emmanuel Aris, Simon Bourne, et al.
10.1136/thoraxjnl-2016-209023

Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial
Eugenio Paci, Donella Puliti, Andrea Lopes Pegna, et al.
10.1136/thoraxjnl-2016-209825

2016

Blood eosinophils and inhaled corticosteroid/long-acting beta-2 agonist efficacy in COPD
Ian D. Pavord, Sally Lettis, Nicolas Locantore, et al.
10.1136/thoraxjnl-2015-207021

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
Andres Floto, Kenneth N. Olivier, Lisa Saiman, et al.
10.1136/thoraxjnl-2015-207360

Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry
Joan Sweeney, Chris C. Patterson,Andrew Menzies-Gow, et al.
10.1136/thoraxjnl-2015-207630

UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening
K. Field, S. W. Duffy, D. R. Baldwin, et al.
10.1136/thoraxjnl-2015-207140

Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study
Matthew Maddocks, Samantha S. C. Kon, Jane L. Canavan, et al.
10.1136/thoraxjnl-2016-208460

International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
Alexandra L. Quittner, Janice Abbott, Anna M. Georgiopoulos, on behalf of the International Committee on Mental Health, et al.
10.1136/thoraxjnl-2015-207488

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
Andres Floto, Kenneth N. Olivier, Lisa Saiman, et al.
10.1136/thoraxjnl-2015-207983

Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts
J. McDonnell, S. Aliberti, P. C. Goeminne, et al.
10.1136/thoraxjnl-2016-208481

Cherry-flavoured electronic cigarettes expose users to the inhalation irritant, benzaldehyde
Leon Kosmider, Andrzej Sobczak, Adam Prokopowicz, et al.
10.1136/thoraxjnl-2015-207895

Interobserver agreement for the ATS/ERS/JRS/ALAT criteria for a UIP pattern on CT
Simon L. F. Walsh, Lucio Calandriello, Nicola Sverzellati, on behalf of The UIP Observer Consort, et al.
10.1136/thoraxjnl-2015-207252